When used regularly, D’OXYVA® (deoxyhemoglobin vasodilator) improves microcirculation and promotes the blood flow in the smallest blood vessels to deliver important nutrients and oxygen to organs and cells, which in turn supports the body’s own self-healing powers, enabling you to be active again.
Clinical studies with D’OXYVA have shown extraordinary results for the role of transdermal noninvasive wound care using ultra-purified, nontoxic, FDA-cleared molecules, such as CO2, especially when all other approaches failed.
In an ongoing multiyear, multi-country, multicenter, randomized clinical trial on patients with diabetic foot ulcers, D’OXYVA has demonstrated speeding up diabetic wound healing and ultimately wound closure to an average of 5 weeks**.
In addition, D’OXYVA eliminated pain and improved quality of life factors such as sleep, appetite, and mood in just a week in 100% of subjects. No adverse events of any kind were reported during, and years after, the studies.
Patients and physicians report quicker, more comfortable diabetic wound treatment, wound closure, and overall recovery from trauma and so-called nonhealing chronic wounds related to diabetes and cardiovascular complications. Reports of significantly lower instances of pain and infection are nearly universal.
- PAIN-FREE, NONINVASIVE, NONELECTRICAL, TAKES 5 MINUTES
- AFFORDABLE, CONVENIENT, MAJOR CLINICAL OUTCOMES IN 2-6 WEEKS**
- PATIENT- & DOCTOR-FRIENDLY; USE AT HOME, IN PRACTICE, OR ON THE GO
- NONTOXIC, NON-OPIOID, NO ADVERSE SIDE EFFECTS, NO OVERDOSE
- HANDHELD, PORTABLE, NEEDS NO SPECIAL STORAGE
- EFFECTIVE STANDALONE & ADJUNCT SOLUTION, NO ADVERSE INTERFERENCE WITH OTHER MODALITIES
MEASURE / FEEL / SEE RESULTS IN 5 WEEKS**
*Six years of excellent user feedback and over two dozen clinical studies demonstrated outsized results at clinics and at home with zero adverse events. For example, significant results have also been recorded for D’OXYVA® (deoxyhemoglobin vasodilator) as a varicose vein treatment while delivering major clinical outcomes for well over 90% of users. Average results are rounded for display, based on number of enrolled subjects in each clinical study with D’OXYVA and user feedback. Read D’OXYVA Clinical Evidence >
**Individual results may vary. Ask your doctor before taking D’OXYVA. For prescription for medical use. Read D’OXYVA Regulatory Statements >
***We will refund your entire D’OXYVA purchase price if you do not experience any improvements (proof of purchase required, improvements of blood flow [perfusion index] measured from absolute baseline without taking D’OXYVA). Read Circularity’s Return Policy >